Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 8—August 2025

Dispatch

Neurologic Manifestations Associated with Parvovirus B19 Epidemic, Madrid, Spain, 2024

Cristina VeintimillaComments to Author , Pilar Catalán, Agustín Estévez, Roberto Alonso, Maricela Valerio, and Patricia Muñoz
Author affiliation: Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain (C. Veintimilla, P. Catalán, A. Estévez, R. Alonso, M. Valerio, P. Muñoz); Instituto de Investigación Sanitaria Gregorio Marañón, Madrid (C. Veintimilla, P. Catalán, A. Estévez, R. Alonso, M. Valerio, P. Muñoz); School of Medicine, Universidad Complutense de Madrid, Madrid (P. Catalán, R. Alonso, M. Valerio, P. Muñoz); Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Madrid (P. Muñoz)

Main Article

Figure 2

Clinical timelines for case-patients with neurologic manifestations associated with parvovirus B19 epidemic, Madrid, Spain, 2014–2024. CSF, cerebrospinal fluid.

Figure 2. Clinical timelines for case-patients with neurologic manifestations associated with parvovirus B19 epidemic, Madrid, Spain, 2014–2024. CSF, cerebrospinal fluid.

Main Article

Page created: July 02, 2025
Page updated: July 14, 2025
Page reviewed: July 14, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external